Jianjun Chen
Molecular Biology · Cancer Cell · 2016–2020
A researcher in the Science corpus: 9 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 281 citations into it; #16,514 of 17,773 by trust here, #3,866 by citations
Whom Jianjun Chen trusts
Their strongest outbound trust, strongest first, inferred from their citations.
- Chuan He (in Molecular Biology)
- I. A. Roundtree (in Molecular Biology)
Who trusts Jianjun Chen
- Chuan He (in Molecular Biology)
Papers from Jianjun Chen's perspective
Ordered by how strongly the researchers Jianjun Chen trusts endorse each paper. Same corpus, a different order for every researcher.
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility (Molecules and Cells)
- Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase (Cell Research)
- Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq (Nature)
- N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO (Nature Chemical Biology)
- N6-methyladenosine Modulates Messenger RNA Translation Efficiency (Cell)
- METTL3 promotes translation in human cancer cells (Molecules and Cells)
- m6A RNA methylation promotes XIST-mediated transcriptional repression
- Structural basis of N6-adenosine methylation by the METTL3–METTL14 complex (Nature)
- m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells (Cell Reports)
- Single-nucleotide resolution mapping of m6A and m6Am throughout the transcriptome (Nature Methods)
Their papers
- FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase (2016) — 1,299 citations
- Recognition of RNA N6-methyladenosine by IGF2BP Proteins Enhances mRNA Stability and Translation (2018) — 2,518 citations
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling (2017) — 977 citations
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification (2017) — 860 citations
- m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer (2020) — 1,040 citations
- Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in Cell Nucleus and Cytoplasm (2018) — 646 citations
- Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia (2019) — 772 citations
- RNA N6-methyladenosine modification in cancers: current status and perspectives (2018) — 614 citations
- Targeting FTO suppresses cancer stem cell maintenance and immune evasion (2020) — 658 citations